Best Peptide Stacks for Longevity and Anti-Aging: The 2026 Science-Based Protocol

Educational guide for research and informational purposes only. Not medical advice.

Longevity science has shifted from a philosophical aspiration to a mechanistic discipline. The hallmarks of aging — a framework established by Lopez-Otin et al. (2013) and expanded in 2023 — provide a biological taxonomy of what aging actually is: genomic instability, telomere attrition, epigenetic dysregulation, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and disabled autophagy.

Effective longevity interventions don't address one of these — they address several simultaneously. The compounds in the longevity stack were selected for their mechanistic coverage across multiple aging pathways, their evidence base in peer-reviewed research, and their complementarity.

The Hallmarks Framework — What You're Intervening Against

Before reviewing the compounds, it's worth establishing what each is targeting:

Core Longevity Stack Components

1. Epithalon — Telomerase Activation and Pineal Restoration

Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from epithalamin, the active polypeptide fraction of the bovine pineal gland. It is one of the most extensively studied peptide bioregulators, with over 40 years of research from Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology.

Primary mechanisms:

• Telomerase activation — Epithalon has been shown to activate telomerase (hTERT) in human somatic cells that normally do not express it, leading to telomere elongation; this was demonstrated in human fetal fibroblasts, retinal cells, and T-lymphocytes in vitro
• Melatonin restoration — stimulates pineal production of melatonin in aged animals; plasma melatonin levels increased significantly in aged rats treated with epithalamin extract (the natural precursor)
• Antioxidant upregulation — increases superoxide dismutase and glutathione peroxidase activity
• Oncostatic effects — reduces tumor incidence and slows tumor growth in multiple animal carcinogenesis models; this is attributed to DNA repair support and immune modulation
• Lifespan extension — in multiple rodent strains, epithalamin or Epithalon treatment extended mean and maximum lifespan by 20–30%; this remains among the strongest lifespan extension data for any peptide compound

Protocol: Typically 5–10mg daily for 10 consecutive days, 2–3 times per year. Subcutaneous or intranasal delivery. Cycles may be adjusted based on individual aging markers.

2. NAD+ — The Longevity Cofactor

NAD+ decline is one of the most consistent biochemical features of aging across species. In humans, tissue NAD+ falls by approximately 50% between young adulthood and middle age. This decline directly impairs:

• All seven sirtuin deacetylases (SIRT1–7), which regulate DNA repair, mitochondrial biogenesis, inflammation, and circadian rhythmicity
• PARP enzymes responsible for DNA single-strand break repair
• CD38 signaling, which consumes NAD+ in immunological contexts

Supplementing NAD+ precursors (NMN, NR) or direct NAD+ raises tissue levels and restores sirtuin activity. Human clinical trials have demonstrated improved skeletal muscle NAD+ metabolism, reduced inflammatory markers, and improved insulin sensitivity in older adults. The longevity mechanism is primarily through SIRT1 (PGC-1α activation, mitochondrial biogenesis) and SIRT6 (DNA repair, genomic stability).

NAD+ 500mg

3. MOTS-C — Mitochondrial Signaling for Metabolic Health

MOTS-C is a mitochondria-encoded peptide whose plasma levels decline with age and are reduced in metabolic disease states. Its AMPK-activating mechanism is directly relevant to longevity: AMPK is the cellular energy sensor that, when activated, shifts metabolism away from anabolic storage (fat deposition, protein synthesis of non-essential proteins) toward catabolic maintenance (autophagy, mitochondrial quality control, fat oxidation).

MOTS-C's relevance to longevity: AMPK activation mimics some of the effects of caloric restriction — one of the most reproducible lifespan-extending interventions across species. It also activates Nrf2 target genes that govern cellular antioxidant defenses, and reduces inflammatory NF-κB signaling.

MOTS-C 10mg

4. SS-31 (Elamipretide) — Mitochondrial Membrane Integrity

Mitochondrial inner membrane integrity — specifically, the structural relationship between cardiolipin and ETC complexes — degrades progressively with age. This is one of the primary drivers of declining ATP production efficiency, increasing electron leak (and ROS generation), and declining mitochondrial reserve capacity that characterizes aging tissues.

SS-31 specifically targets and stabilizes this cardiolipin-complex relationship. In aged animal models, SS-31 restored mitochondrial respiration rate to young-adult levels, reduced age-associated ROS production, and improved exercise capacity and tissue function. It is currently the most mechanistically targeted inner mitochondrial membrane compound in peptide research.

5. GHK-Cu — Epigenetic and Tissue Regeneration

GHK-Cu's bioinformatic analysis by Pickart and Margolina identified modulation of over 4,000 human genes — including genes that are dysregulated in cancer, cognitive decline, and aging. The pattern of gene expression changes produced by GHK-Cu is toward a younger phenotype: increased collagen, reduced inflammatory signaling, upregulated antioxidant defense, improved DNA repair gene expression.

GHK-Cu plasma levels are high in young adults and decline significantly with age — following the same pattern as GH, IGF-1, melatonin, and other regenerative signals. This decline is not coincidental; GHK-Cu is an endogenous regulator of tissue homeostasis whose loss contributes to the age-related decline in regenerative capacity.

GHK-Cu 50mg

6. Thymosin Alpha-1 — Immune Competence in Aging

Immunosenescence — the progressive decline of immune function with age — is a primary driver of both infectious disease susceptibility and cancer incidence in older adults. The thymus, responsible for T-cell maturation, involutes significantly after middle age, reducing the production of naive T cells and impairing adaptive immune response.

Thymosin Alpha-1 (Ta1) restores T-cell function in aged immune systems, improves NK cell cytotoxicity, and reduces the pro-inflammatory cytokine milieu ("inflammaging") characteristic of aging immune systems. It has clinical approval in multiple countries for infectious disease and cancer immunotherapy adjuvant use — a regulatory recognition of its biological activity that most longevity compounds lack.

Supporting Compounds

GH Axis Optimization

Growth hormone declines by approximately 14% per decade after young adulthood (the "somatopause"). This decline contributes to: increased visceral fat, reduced lean mass, reduced bone density, impaired cognitive function, reduced skin thickness, and impaired tissue repair capacity. GH secretagogues — CJC-1295, Ipamorelin, sermorelin — restore pulsatile GH release without shutting down the feedback axis.

• CJC-1295 / Ipamorelin Blend — the most commonly used GH axis optimization combination

Pinealon

Neuroprotective tripeptide targeting pineal neuron function, circadian gene regulation, and neuronal oxidative defense. Particularly relevant for cognitive longevity and circadian health, both of which deteriorate with age.

BPC-157

Systemic tissue repair, anti-inflammatory, and GI health — relevant for the inflammaging component of biological aging and for maintaining the GI epithelial integrity that supports nutrient absorption and immune exclusion.

Wolverine (BPC-157 / TB-500)

Protocol Architecture — Timing and Cycling

Longevity protocols are long-game interventions. The goal is not acute physiological response but sustained upregulation of maintenance and repair systems over years and decades. This calls for cycling protocols rather than continuous use:

• NAD+ — continuous or near-continuous use; taken daily or several times per week; precursor supplementation (NMN/NR) is a lower-intervention alternative
• MOTS-C — daily or every-other-day SC injection; continuous use protocols common
• SS-31 — daily SC; may be cycled (2 weeks on / 2 weeks off) to maintain receptor sensitivity
• Epithalon — 10-day courses, 2–4 times per year (Khavinson institute standard protocol)
• Thymosin Alpha-1 — 2x per week SC; 4–8 week courses with breaks; or continuous lower-frequency maintenance
• GHK-Cu — daily or every-other-day; can run continuously at lower doses
• GH secretagogues — daily pre-sleep injection; 20–26 week cycles with 4–8 week breaks

Lab Monitoring for Longevity Protocols

• IGF-1 — GH axis activity; should be at upper quartile of age-adjusted range
• Inflammatory markers — hs-CRP, IL-6; target improvement over 12–24 weeks
• NAD+ (blood test) — available through specialty labs; confirms repletion
• Comprehensive metabolic panel — liver, kidney, glucose, electrolytes
• Hormonal panel — testosterone, estradiol, DHEA-S, thyroid; longevity is incompatible with untreated hormonal deficiency
• Biological age assessment — epigenetic clock (GrimAge, DunedinPACE) at baseline and annually; the most direct measure of whether the protocol is affecting aging trajectory
• Doctor's Consultation — annual minimum for longevity protocol review and biomarker-guided adjustment

References

1. Lopez-Otin C, et al. The Hallmarks of Aging. Cell. 2013;153(6):1194–1217. (Updated 2023)
2. Khavinson VK, et al. Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells. Bull Exp Biol Med. 2003;135(6):590–592.
3. Guarente L. Sirtuins, Aging, and Medicine. N Engl J Med. 2011;364(23):2235–2244.
4. Szeto HH. First-in-Class Cardiolipin-Protective Compound as a Therapeutic Agent to Restore Mitochondrial Bioenergetics. Br J Pharmacol. 2014;171(8):2029–2050.
5. Lee C, et al. MOTS-c: A Mitochondrial-Derived Peptide Regulates Muscle and Fat Metabolism. Cell Metab. 2015;21(3):443–454.
6. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. 2018;19(7):1987.
7. Goldstein AL, et al. Thymosin Alpha-1 in the Treatment of Cancer. Expert Opin Biol Ther. 2009.

Educational Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before initiating any longevity protocol.

FitAF Performance — Educational content only.